Dawn of a new era - Hyper-acceleration of R&D productivity

09:30am

Yiannis Kiachopoulos | CEO and Co-Founder, Causaly

In the opening address, Yiannis Kiachopoulos, CEO and Co-founder of Causaly explores the transformative impact of AI on R&D productivity. Gain insights into the present challenges impeding R&D output and how AI can be applied to acceelerate innovation and efficiency to substantially augment Pharma R&D, propelling the industry into a new era of accelerated development and impactful breakthroughs.

Driving Discovery with AI: Inside Novartis’ Approach

10:00am

Birgit Schoeberl | Global Head of Data Science, Novartis

Explore the practical side of AI with insights from Novartis' VP for Translational Modeling & Simulation and Data Science. Learn about Novartis’ internal AI initiatives with real-world use cases, including applications across predictive safety and target identification. This talk offers a firsthand look into successful AI strategies, including specific efforts in early development and discovery at Novartis, equipping attendees with actionable insights for their AI implementation journey.

[Fireside chat] AI and the Enterprise: Imagining the possibilities and debunking the myths

11:15am

Anantha Kancherla | Engineer, Meta

Artur Saudabayev | CTO and Co-Founder, Causaly

In this fireside chat between Anantha Kancherla, the Former Head of AI Platform at Meta, and Artur Saudabayev, CTO & Co-founder of Causaly, get a balanced, forward-thinking perspective on AI-enabled enterprise transformation. Anantha and Artur will disentangle expectations from reality,  while offering their point of view on how the technology is poised to evolve and how organizations should prepare.

Lessons from Takeda: Laying the foundations to accelerate the path from data to insight

12:00pm

Sean Liu | Head of Scientific Assets & Decision Support, Takeda

This talk will provide a view into Takeda's blueprint for developing a connected, end-to-end data platform designed to transform information into knowledge. Learn how they are advancing the development of a global data and analytics platform, with a specific application in better lead identification and optimization. Explore their efforts in overcoming data silos, enabling streamlined access and insights into diverse datasets, and fostering efficient communication within the organization. 

Fireside Chat

02:00pm

Alex Gorsky | Former Chairman and CEO, Johnson & Johnson

Yiannis Kiachopoulos | CEO and Co-Founder, Causaly

A fireside chat between Alex Gorsky, Former Chairman and Chief Executive Officer of Johnson and Johnson, and Yiannis Kiachopoulos, CEO and Co-founder of Causaly. Alex will share his perspective on the profound impacts of emerging technologies on healthcare more broadly. Jointly, Alex and Yiannis will explore the unfolding future of AI-integrated biomedical research, drug development and healthcare solutions. 

Unlocking the Genomic Odyssey: Inspiring our scientists to discover new targets

02:45pm

Eric Adam | Global Head of Operations, Neuroscience and Rare Diseases, Roche

Navigate the complex world of neurology with Eric Adams, the Global Head of Operations, Neuroscience, and Rare Diseases at Roche. In a field marked by immense scientific challenges and unique hurdles to target discovery, emerging consortia and seminal research are rewriting the landscape. 

This session sheds light on innovative approaches to unearthing new neuro targets, offering a detailed glance into Roche's exploratory journey in this dynamic domain.

From Discovery to Triage: Improving the target selection process with multi-modal data

03:25pm

Kevin Munnelly | SVP, Platform technologies, Third Rock Ventures

Gain insights into the use of multi-modal data for robust target identification and triage spanning genetics, disease, molecular and cellular biology, disease models, pharmacology, and clinical aspects. Learn about the advanced methodologies and technologies employed for improving the target selection process, including the integration of tools like Causaly for enhanced mechanistic evidence.

Causaly Evolution and Future Direction

04:30pm

Yiannis Kiachopoulos | CEO and Co-Founder, Causaly

Join us as we unveil a live demonstration of the Causaly Co-pilot, offering a glimpse into the exciting future of how the creative power and flexibility of LLMs can be combined with the high precision and verifiability of knowledge graphs for biomedical research. We also share details about our product roadmap, and strategic areas of focus for customer collaboration over the next 6-12 months.

The 100x Scientist - Amplifying innovation with AI

09:30am

Stavroula Ntoufa | Director of Scientific Affairs, Causaly

Cartic Ramakrishnan | VP of Applied AI, Causaly

[Panel Discussion] Traversing the AI Frontier

10:00am

Birgit Schoeberl | Global Head of Data Science, Novartis    

Eric Adam | Global Head of Operations, Neuroscience and Rare Diseases, Roche

Justin H. Johnson | Executive Director, Oncology Data Science, AstraZeneca

Caroline Xie | General Partner at ICONIQ Growth

Uncharted Waters: Navigating the evolving policy landscape of AI in Healthcare

11:00am

Christina Silcox | Research Director for Digital Health, Duke-Margolis Center

As AI and digital health technologies evolve at unprecedented pace, navigating changes in the policy landscape is also crucial. In her talk, Christina will delve into the latest policy developments, initiatives and frameworks laid out by various U.S. and global agencies, including the FDA, focusing on the use of AI in health and medical product development.

Deploying AI into the Enterprise

11:30am

Bob van Luijt | Co-founder & CEO, Weviate

In this talk, Bob Van Luijt, Co-founder & CEO of Weaviate, takes us through what you need to know to effectively deploy AI systems into your organization. He breaks down in simple terms the known limitations of current AI models and approaches, how to measure and understand errors and risks, and appropriate mitigation measures. Through a combination of examples from other industries and stories from the field, Bob shares his insights and lessons on what to expect and consider in your own digital transformations.

Outlook: Re-imagining the R&D organization of the future

12:00am

Artur Saudabayev | CTO and Co-Founder, Causaly

In his closing address, Artur Saudabayev, CTO and Co-founder of Causaly wraps up the conference with his key takeaways. He imagines how the landscape of R&D organizations will be reshaped by innovative AI applications, enhanced collaborative frameworks, and accelerated discovery pathways.